hasRegulatoryApproval
P24602
predicate
Indicates that an entity has received formal authorization or clearance from a relevant regulatory authority to operate, be sold, or be used in a specified context.
All labels observed (16)
| Label | Occurrences |
|---|---|
| regulatoryApproval | 58 |
| hasRegulatoryApproval canonical | 25 |
| regulatoryApprovedExample | 8 |
| regulatoryApprovalFor | 6 |
| regulatoryApprovalForCoronaVac | 5 |
| regulatoryApprovalIn | 5 |
| hasRegulatoryApprovalFor | 3 |
| approvedForMedicalUse | 2 |
| hasFDAApprovalStatus | 2 |
| hasRegulatoryAgencyApproval | 2 |
| FDAApprovalStatus | 1 |
| hasFDAApprovalFor | 1 |
| hasRegulatoryDesignation | 1 |
| regulatorApproval | 1 |
| regulatoryAuthorization | 1 |
| regulatoryClearance | 1 |
Description generation (PDg)
The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.
Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning. # Instructions Focus on describing the relationship, not the entities themselves. # Response Format Begin the description with \' Indicates...\'
Input
Predicate: hasRegulatoryApproval
Generated description
Indicates that an entity has received formal authorization or clearance from a relevant regulatory authority to operate, be sold, or be used in a specified context.
Sample triples (122)
| Subject | Object |
|---|---|
| Samsung Bioepis | Canada via predicate surface "regulatoryApprovalIn" NERFINISHED ⓘ |
| Samsung Bioepis | Australia via predicate surface "regulatoryApprovalIn" NERFINISHED ⓘ |
|
ebastine
surface form:
Ebastine
|
approved in various European and Asian countries ⓘ |
| Portola Pharmaceuticals | Andexxa FDA approval via predicate surface "regulatoryApproval" ⓘ |
| Portola Pharmaceuticals | Bevyxxa FDA approval via predicate surface "regulatoryApproval" ⓘ |
| Millennium Pharmaceuticals | Velcade via predicate surface "regulatoryApprovalFor" NERFINISHED ⓘ |
| Teprotumumab | FDA NERFINISHED ⓘ |
| GW Pharmaceuticals | Epidiolex FDA approval 2018 via predicate surface "regulatoryApproval" ⓘ |
| GW Pharmaceuticals | Epidiolex EMA approval 2019 via predicate surface "regulatoryApproval" ⓘ |
| GW Pharmaceuticals | Sativex approvals in multiple countries via predicate surface "regulatoryApproval" ⓘ |
| fenfluramine | treatment of Dravet syndrome in children via predicate surface "hasRegulatoryApprovalFor" ⓘ |
| fenfluramine | treatment of Lennox–Gastaut syndrome in patients aged 2 years and older via predicate surface "hasRegulatoryApprovalFor" ⓘ |
| neratinib | FDA-approved via predicate surface "regulatoryApproval" ⓘ |
| neratinib | EMA-approved via predicate surface "regulatoryApproval" ⓘ |
| fam-trastuzumab deruxtecan | U.S. Food and Drug Administration NERFINISHED ⓘ |
| fam-trastuzumab deruxtecan | European Medicines Agency NERFINISHED ⓘ |
| LOT Aircraft Maintenance Services | EASA Part-145 via predicate surface "regulatoryApproval" NERFINISHED ⓘ |
| LOT Aircraft Maintenance Services | EASA Part-147 via predicate surface "regulatoryApproval" NERFINISHED ⓘ |
| LOT Aircraft Maintenance Services | EASA Part-M via predicate surface "regulatoryApproval" NERFINISHED ⓘ |
| Abraxis BioScience | U.S. FDA approval for Abraxane in metastatic breast cancer via predicate surface "regulatoryApproval" ⓘ |
| Abraxis BioScience | U.S. FDA approval for Abraxane in non-small cell lung cancer via predicate surface "regulatoryApproval" ⓘ |
| Abraxis BioScience | U.S. FDA approval for Abraxane in pancreatic cancer via predicate surface "regulatoryApproval" ⓘ |